Anna Schöni, PhD, is an epidemiologist and a postdoc at BIHAM. She works on a clinical trial that is testing whether vaporizers are an effective intervention for smoking cessation. Dr. Schöni received her PhD in epidemiology at the Swiss Tropical and Public Health Institute, associated Institute of the University of Basel. Before starting her PhD studies, she received her master’s and bachelor’s degree in Biomedical Sciences at the Universities of Fribourg and Bern.
